FDA Issues Warning of Cancer Risk Tied to CAR-T Therapies

The agency has reviewed reports of cancer patients whose treatments resulted in the development of secondary blood cancers. Several companies will be required to carry the new warning.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Cancer Immunotherapy Blood Deaths (Fatalities) Genetic Engineering Labeling and Labels (Product) Food and Drug Administration Bristol Myers Squibb Company Janssen Pharmaceutica Juno Therapeutics Inc Kite Pharma Inc Novartis AG Source Type: news